Evidence map›Paper›PMID 41278221›Full record

ReviewPublic health in practice (Oxford, England)2025

Medicaid reimbursement policies for long-acting reversible contraceptives immediately postpartum: A systematic literature review.

Greta Lozano-Ortega, Sarah E Walker, Simone Crespi, Emilia Kourmaeva, Vanessa Perez Patel

Abstract readReview
In one paragraph

Review in Public health in practice (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Greta Lozano-OrtegaBroadstreet HEOR, Vancouver, BC, Canada.
Sarah E WalkerBroadstreet HEOR, Vancouver, BC, Canada.
Simone CrespiOrganon & Co, Jersey City, New Jersey, United States.
Emilia KourmaevaBroadstreet HEOR, Vancouver, BC, Canada.
Vanessa Perez PatelOrganon & Co, Jersey City, New Jersey, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Medicaid reimbursement for long-acting reversible contraceptives provisioned immediately postpartum (IPP-LARC) has historically been included as part of the diagnosis-related group (DRG) fee for delivery. To rectify this financial disincentive, policies to reimburse hospitals for IPP-LARC, supplemental to the DRG fee, were implemented. This review synthesizes the impact of these policies. Study design: Systematic literature review. Methods: A search in Medline, EMBASE, and CINAHL was executed on November 21, 2022. Impacts on uptake of IPP-LARC, short-interval pregnancy, and author conclusions were synthesized. Results: Twenty studies reporting on Medicaid reimbursement policies across 15 states were included. The average age of women across study populations ranged from 22.2 to 31.0 years; populations were racially, and ethnically diverse; primarily urban hospitals were included. Sixteen studies reported on uptake and 7 studies reported on birth outcomes. Statistically significant increases in uptake after policy implementation were reported in 9 studies across Delaware, Georgia, New York, Rhode Island, Wisconsin, Washington, Louisiana, Missouri, and South Carolina. Policy implementation in South Carolina and Ohio resulted in significantly lower rates of short-interval pregnancy, as reported in 6 studies. Smaller, rural, and religiously affiliated hospitals were significantly less likely to leverage Medicaid policies for IPP-LARC. Key determinants of increased uptake were provider champion advocacy, co-interventions for training hospital staff, and relieving the up-front financial burden associated with stocking LARCs. Conclusions: Medicaid reimbursement policies targeting IPP-LARC access are associated with increased adoption and reduced short-interval pregnancy. Co-interventions supporting hospitals and individuals who are immediately postpartum would further facilitate IPP-LARC access.

Indexed as

Long-acting reversible contraceptivesMedicaidPostpartumReproductive health

Identifiers

PMID41278221
PMCPMC12639324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.